<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>12</Volume><Issue>5</Issue><PubDate PubStatus="epublish"><Year>2021</Year><Month>09</Month><Day>29</Day></PubDate></Journal><title locale="en_US">Preventive Effect of Eucalyptol on the Formation of Aorta Lesions in the Diabetic‑Atherosclerotic Rat</title><FirstPage>2456</FirstPage><LastPage>2456</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Clinical Biochemistry, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabi</affiliation></Author><Author><affiliation locale="en_US">Department of Endocrinology and Metabolism, Faculty of Medicine, Tehran University of Medical Sciences, Tehran</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2021</Year><Month>09</Month><Day>08</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span id="page622R_mcid47" class="markedContent"&gt;&lt;span dir="ltr"&gt;&lt;strong&gt;Background&lt;/strong&gt;:&lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid48" class="markedContent"&gt;&lt;span dir="ltr"&gt; Glycation, inflammation, and oxidative stress are the cardinal motivators of diabetes &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid49" class="markedContent"&gt;&lt;span dir="ltr"&gt;vascular complications. Here, we studied the effect of eucalyptol&lt;/span&gt;&lt;span dir="ltr"&gt;(EUC) on the formation of &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid50" class="markedContent"&gt;&lt;span dir="ltr"&gt;atheromatous lesions, glycation, oxidative stress, and inflammatory markers as well as insulin &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid51" class="markedContent"&gt;&lt;span dir="ltr"&gt;resistance, lipid profile, and activity of glyoxalase‑1&lt;/span&gt;&lt;span dir="ltr"&gt;(GLO‑I) in the atherosclerotic rat model. &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid52" class="markedContent"&gt;&lt;br /&gt;&lt;span dir="ltr"&gt;&lt;strong&gt;Methods&lt;/strong&gt;: &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid53" class="markedContent"&gt;&lt;span dir="ltr"&gt;Diabetic‑atherosclerosis induced in rats with a combination of streptozotocin and &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid54" class="markedContent"&gt;&lt;span dir="ltr"&gt;atherogenic diet. Two groups of rats, normal and diabetic‑atherosclerotic, were treated intragastrically &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid55" class="markedContent"&gt;&lt;span dir="ltr"&gt;with EUC&lt;/span&gt;&lt;span dir="ltr"&gt;(200 mg/kg) once daily for 3 months. Fasting blood sugar&lt;/span&gt;&lt;span dir="ltr"&gt;(FBS), insulin, insulin resistance &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid56" class="markedContent"&gt;&lt;span dir="ltr"&gt;index, lipid profile, the activity of GLO‑I, low‑density lipoprotein&lt;/span&gt;&lt;span dir="ltr"&gt;(LDL) glycation and oxidation &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid57" class="markedContent"&gt;&lt;span dir="ltr"&gt;markers, inflammatory markers, creatinine in the serum, and proteinuria in the urine of all rats were &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid58" class="markedContent"&gt;&lt;br /&gt;&lt;span dir="ltr"&gt;determined. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span id="page622R_mcid59" class="markedContent"&gt;&lt;span dir="ltr"&gt;&lt;strong&gt;Results&lt;/strong&gt;:&lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid60" class="markedContent"&gt;&lt;span dir="ltr"&gt; EUC inhibited the formation of any atheromatous lesions in atherosclerotic &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid61" class="markedContent"&gt;&lt;span dir="ltr"&gt;rats. Further, EUC displayed the lowering effect on glycemia, insulin resistance, LDL glycation, &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid62" class="markedContent"&gt;&lt;span dir="ltr"&gt;and oxidation products, and tumor necrosis factor&lt;/span&gt;&lt;span dir="ltr"&gt;(TNF)‑&lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid63" class="markedContent"&gt;&lt;span dir="ltr"&gt;α&lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid64" class="markedContent"&gt;&lt;span dir="ltr"&gt; as well as it exhibited the improving &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid65" class="markedContent"&gt;&lt;br /&gt;&lt;span dir="ltr"&gt;effect on lipid profile, the activity of GLO‑I, and renal function in the diabetic rat&lt;/span&gt;&lt;span dir="ltr"&gt;(&lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid66" class="markedContent"&gt;&lt;span dir="ltr"&gt;P&lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid67" class="markedContent"&gt;&lt;span dir="ltr"&gt;&amp;lt;&lt;/span&gt;&lt;span dir="ltr"&gt;0.001). &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid68" class="markedContent"&gt;&lt;br /&gt;&lt;span dir="ltr"&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;:&lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid69" class="markedContent"&gt;&lt;span dir="ltr"&gt; EUC prevented the formation of the atheromatous lesions and improved renal function &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid70" class="markedContent"&gt;&lt;span dir="ltr"&gt;in the atherosclerotic rat model due to a reduction of glycation, oxidative stress, and inflammatory &lt;/span&gt;&lt;/span&gt;&lt;span id="page622R_mcid71" class="markedContent"&gt;&lt;br /&gt;&lt;span dir="ltr"&gt;mediators.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2456</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2456/717718295</pdf_url></Article></Articles>
